valproic acid 250 mg

INDICATIONS AND USAGE Valproic acid is indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures. Valproic acid is indicated for use as sole and adjunctive therapy in the treatment of simple and complex absence seizures, and adjunctively in patients with multiple seizure types which include absence seizures. Simple absence is defined as very brief clouding of the sensorium or loss of consciousness accompanied by certain generalized epileptic discharges without other detectable clinical signs. Complex absence is the term used when other signs are also present. SEE WARNINGS FOR STATEMENT REGARDING FATAL HEPATIC DYSFUNCTION.

rebel distributors corp

FDA Reported Adverse Reactions
`[1] off label use` `[2] fatigue` `[3] drug ineffective` `[4] pain` `[5] nausea` `[6] headache` `[7] arthralgia` `[8] pyrexia` `[9] dyspnoea` `[10] toxicity to various agents`

6 months ago

OVAL WHITE PA2120

HOW SUPPLIED Each white, oblong softgel (soft-gelatin capsule) imprinted PA2120, contains 250 mg valproic acid in bottles of 100's. The softgels should be protected from moisture and humidity and stored between 59-77°F (15-25°C) as per the container label. Dispense in a tight, light-resistant container as defined in the USP/NF. Maalox® is a registered trademark of Novartis Consumer Health Canada Inc. Titralac TM is a registered trademark of 3M.

More pills like OVAL PA2120

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

valproic acid 250 mg

FDA Reported Adverse Reactions [1] off label use [2] fatigue [3] drug ineffective [4] pain [5] nausea [6] headache [7] arthralgia [8] pyrexia [9] dyspnoea [10] toxicity to various agents

OVAL WHITE PA2120

More pills like OVAL PA2120

FDA Reported Adverse Reactions
`[1] off label use` `[2] fatigue` `[3] drug ineffective` `[4] pain` `[5] nausea` `[6] headache` `[7] arthralgia` `[8] pyrexia` `[9] dyspnoea` `[10] toxicity to various agents`